Related Experiment Video
Updated: Apr 29, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
1.6K
Acute myocardial infarction complicating active ulcerative colitis: a case report.
Eva D Papadimitraki1, Mubarak Ahamed1, Nicholas H Bunce1
1Department of Cardiology, St George's Hospital, Blackshaw Road, London SW17 0QT, UK.
Case Reports in Cardiology
|May 15, 2014
Summary
Ulcerative colitis patients may face cardiac risks, including myocardial infarction, especially with specific antibodies and elevated factor VIII. Cardiac MRI aids in diagnosing heart damage in these inflammatory conditions.
Area of Science:
- Cardiology
- Gastroenterology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with potential extraintestinal manifestations.
- Cardiac involvement in UC, such as pericarditis and myocarditis, is known, but links to ischemic heart disease are less clear.
Observation:
- A 27-year-old male with anti-PRIII ANCA-positive UC and elevated factor VIII activity presented with acute myocardial infarction.
- This case highlights an unusual presentation of cardiac complications in a young UC patient.
Findings:
- The patient experienced an acute myocardial infarction, a condition not definitively linked to UC.
- Elevated factor VIII activity and ANCA positivity may indicate an increased thrombotic risk in UC.
Implications:
- This case underscores the importance of considering cardiac events in UC patients, even young ones.
- Cardiac magnetic resonance (CMR) is a valuable tool for evaluating myocardial damage in patients with inflammatory diseases like UC.
- Further research is needed to clarify the association between UC, thrombotic risk factors, and ischemic heart disease.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
33
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
33
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
35
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
35
01:29Drugs for Treatment of Ulcerative Colitis in IBD
701
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
701
01:24Peptic Ulcer Disease II: Pathophysiology
43
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
43
01:28Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K